Fingerprint
Dive into the research topics of 'Randomized Phase II trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-trastuzumab in uterine serous carcinomas that overexpress human epidermal growth factor receptor 2/neu'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically